Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Hepatology

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jhep.2010.08.025PMID 21145798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C.

  2010cited by this paper
• 855 DELETERIOUS EFFECTS OF BETA-BLOCKERS ON SURVIVAL AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN PATIENTS WITH CIRRHOSIS AND REFRACTORY ASCITES

  2010cited by this paper
• Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites

  2010influential reference
• Thrombocytopenia associated with chronic liver disease.

  2008influential reference
• Hyponatremia and mortality among patients on the liver-transplant waiting list.

  2008influential reference
• Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease

  2008cited by this paper
• Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.

  2007cited by this paper
• Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis

  2007influential reference
• TIPS versus paracentesis for cirrhotic patients with refractory ascites.

  2006cited by this paper
• TIPS versus paracentesis for cirrhotic patients with refractory ascites.

  2006influential reference
• Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.

  2005cited by this paper
• A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.

  2005cited by this paper
• Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis

  2005cited by this paper
• Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

  2004cited by this paper
• LIVER FAILURE AND LIVER DISEASE

  2004cited by this paper
• Management of cirrhosis and ascites.

  2004cited by this paper
• Clinical characteristics and outcome of patients with cirrhosis and refractory ascites

  2004cited by this paper
• The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club

  2003cited by this paper
• The North American Study for the Treatment of Refractory Ascites.

  2003cited by this paper
• Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.

  2003cited by this paper
• A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.

  2000cited by this paper
• Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease

  2000influential reference
• A COMPARISON OF PARACENTESIS AND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTING IN PATIENTS WITH ASCITES

  2000cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

  1996cited by this paper
• Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.

  1996cited by this paper
• Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial

  1996cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

  1996cited by this paper
• Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS)

  1995cited by this paper
• A Retrospective Analysis

  1990cited by this paper
• Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

  1988cited by this paper

• Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement.

  2026cites this paper
• EASL Clinical Practice Guidelines on TIPS.

  2025cites this paper
• Predictive value of neutrophil-to-lymphocyte ratio for long-term adverse outcomes in cirrhosis patients post-transjugular intrahepatic portosystemic shunt

  2025cites this paper
• Muscle fat content correlates with postoperative survival of viral-related cirrhosis patients after the TIPS: a retrospective study

  2025cites this paper
• Predicting Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunt Placement: A Review of Existing Models and Future Directions.

  2025cites this paper
• Optimal Patient Selection for TIPS

  2025cites this paper
• Der Transjuguläre Intrahepatische Portosystemische Shunt (TIPS): aktuelle und innovative Konzepte

  2025cites this paper
• Association between preoperative platelet count and transjugular intrahepatic portosystemic shunt procedure-related hemorrhage in cirrhotic patients: a retrospective study

  2025cites this paper
• Hepatic Hydrothorax: A Review

  2025cites this paper
• Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome

  2024cites this paper
• Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality.

  2024cites this paper
• Ascites in cirrhotic patients: a comprehensive review

  2024cites this paper
• Predictors of long-term clinical outcomes after TIPS: An ALTA group study

  2024cites this paper
• French guidelines on TIPS: Indications and modalities

  2024cites this paper
• TIPS et prise en charge de l’hypertension portale chez le patient cirrhotique

  2024cites this paper
• TIPS for Refractory Ascites and Hepatic Hydrothorax

  2024cites this paper
• Positionspapier für die standardisierte Anwendung von Transjugulärem Intrahepatischem Portosystemischem Shunt (TIPS) bei Erwachsenen

  2024cites this paper
• Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd).

  2024cites this paper
• Ascite cirrhotique

  2024cites this paper
• Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd).

  2024cites this paper
• CIRSE Standards of Practice on Transjugular Intrahepatic Portosystemic Shunts

  2024cites this paper
• A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization

  2023cites this paper
• Prise en charge d’une ascite cirrhotique

  2023cites this paper
• Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis

  2023cites this paper
• Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast

  2023cites this paper
• A modified model for predicting mortality after transjugular intrahepatic portosystemic shunt: A multicentre study

  2023cites this paper
• Predictive Accuracy Comparison of Prognostic Scoring Systems for Survival in Patients Undergoing TIPS Placement: A Systematic Review and Meta-analysis.

  2023cites this paper
• Prognostic models in end stage liver disease.

  2023cites this paper
• First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan

  2023cites this paper
• Innovative approaches to the management of ascites in cirrhosis

  2023cites this paper
• Roles of Bilirubin in Hemorrhagic Transformation of Different Types and Severity

  2023cites this paper
• Treatment of refractory ascites: current strategies and new landscape of non-selective beta-blockers.

  2022cites this paper
• The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions

  2022cites this paper
• Prediction of effective percutaneous transhepatic biliary drainage in patients with hepatocellular carcinoma: A multi-central retrospective study

  2022cites this paper
• Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers

  2022cites this paper
• A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement

  2022cites this paper
• Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis

  2022cites this paper
• Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt

  2022cites this paper
• Elective Transjugular Intrahepatic Portosystemic Shunt Using Viatorr Stent-Grafts: A Single-Center Experience from China

  2022cites this paper
• Final safety and efficacy results from a 106 real‐world patients registry with an ascites‐mobilizing pump

  2022cites this paper
• Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China

  2022cites this paper
• Guideline review: transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension—a BSG guideline

  2022cites this paper
• FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts

  2022cites this paper
• FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.

  2022cites this paper
• Imaging-guided interventions modulating portal venous flow: Evidence and controversies

  2022influential citation
• A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS ‐ Modified TIPS Score

  2022cites this paper
• Management of the major complications of cirrhosis: Beyond guidelines.

  2021cites this paper
• Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.

  2021cites this paper
• Small Annexin V–Positive Platelet-Derived Microvesicles Affect Prognosis in Cirrhosis: A Longitudinal Study

  2021cites this paper
• Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation

  2021cites this paper
• A simple nomogram identifies patients with refractory ascites with worse outcome after transjugular intrahepatic portosystemic shunt

  2021cites this paper
• FIPS score : solid but we still need even better !

  2021cites this paper
• The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls

  2021cites this paper
• Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS

  2021cites this paper
• Treatment of refractory ascites with an automated low flow ascites pump in patients awaiting liver transplantation

  2021cites this paper
• External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort

  2021cites this paper
• HIF-1α associated logistic regression model serves for predicting decompensation of hepatitis B cirrhosis

  2021cites this paper
• Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis

  2021cites this paper
• Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020

  2020cites this paper
• Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year Experience

  2020cites this paper
• Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: assessment of ten prognostic models

  2020cites this paper
• Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension

  2020cites this paper
• Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update

  2020cites this paper
• Optimal management of ascites

  2020cites this paper
• TIPS for management of portal-hypertension-related complications in patients with cirrhosis.

  2020cites this paper
• Effect of Strelitzia nicolai seed arils containing bilirubin on Sprague Dawley rats

  2019cites this paper
• Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“

  2019cites this paper
• Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of portal hypertension

  2019cites this paper
• TIPS Indications and Contraindications—Pushing the Limits: Is Earlier Better?

  2019cites this paper
• Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival

  2019cites this paper
• Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“

  2019cites this paper
• Predictors of re-bleeding and mortality among patients with refractory variceal bleeding undergoing salvage TIPS

  2019cites this paper
• Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt

  2019cites this paper
• Current approaches to the management of patients with cirrhotic ascites

  2019cites this paper
• Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals

  2019cites this paper
• Covered Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension : Looking for the Right Patient and the Right Time

  2018cites this paper
• Management of refractory cirrhotic ascites: challenges and solutions

  2018cites this paper
• Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?

  2018cites this paper
• EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.

  2018cites this paper
• Covered Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Looking for the Right Patient and the Right Time

  2018cites this paper
• Predictors and Management of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt: The Current State of Literature

  2018cites this paper
• Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS)

  2018cites this paper
• Comparison of MELD and Child- Pugh Score for the Prediction of Survival in Portal Hypertension Undergoing Transjugular Intrahepatic Portosystemic Shunt

  2017cites this paper
• Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis

  2017influential citation
• Early TIPS for portal hypertensive related bleeding: Is resource or education the reason for failure to show clear survival benefit?

  2017cites this paper
• Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites

  2017cites this paper
• The principles of management of patients with liver cirrhosis complicated by ascites

  2017cites this paper
• Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome

  2017cites this paper
• Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.

  2017cites this paper
• CTA As an Adjuvant Tool for Acute Intra-abdominal or Gastrointestinal Bleeding.

  2017cites this paper
• Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?

  2017cites this paper
• Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.

  2017cites this paper
• A Standardized Assessment of Functional Disability Predicts 1-year Mortality in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites

  2016cites this paper
• The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.

  2016cites this paper
• Therapy of the refractory ascites: Total paracentesis vs. TIPS.

  2016cites this paper
• Serum MicroRNA-122 as A Prognostic Biomarker in Patients with Liver Cirrhosis

  2016cites this paper
• early liver Failure after Transjugular intrahepatic Portosystemic s hunt in Patients with cirrhosis with Model for end-stage liver Disease s core of 12 or less: Incidence, Outcome,

  2016cites this paper
• Le TIPS réalisé avec prothèse couverte améliore la survie sans transplantation des patients atteints d'une cirrhose compliquée d'une ascite récidivante : résultats d'une étude randomisée multicentrique

  2016cites this paper
• Traitement des complications de l’hypertension portale par TIPS en 2016

  2016cites this paper
• [Hepatic hydrothorax].

  2016cites this paper